[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 13, 1976

Medical News

JAMA. 1976;236(24):2725-2733. doi:10.1001/jama.1976.03270250003001

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Fine needle biopsy can reach tumors beyond bronchoscope range  Transthoracic biopsy by fine needle aspiration appears to be gaining acceptance in the United States for diagnosing pulmonary lesions beyond the bronchoscope's reach.One advocate of the technique is Willard A. Fry, MD, assistant professor of surgery at Northwestern University Medical School, Chicago. In a 70-patient series at suburban Evanston Hospital, a Northwestern-affiliated facility where he is senior attending surgeon, Dr Fry told an American College of Chest Physicians meeting in Atlanta, "accuracy in tumor diagnosis is in the 90% range for both primary and metastatic lesions."When the technique falters, he told JAMA MEDICAL NEWS in an interview, it is a matter of not getting the material needed for cytologic study. "When you go into the center of the chest with an eight-inch-long needle that is less than a millimeter in diameter to aspirate material from an area that

×